36-Year-Old Man Nearly Loses His Life Purchasing Counterfeit Drugs Across Borders! Exposing the Dark Underbelly of Counterfeit Drug Trafficking in 10 Countries Worldwide

Last December, Drew, 36, drove more than 250 miles from SAN Antonio, Texas, to Mexico in order to buy cheap Ozempic diet pills. However, when he went home to check the drugs he had bought, he noticed they looked abnormal and shared pictures on social media. After discussion, it was concluded that the drugs that Drew had purchased were fakes. Users on Reddit pointed out that the drugs look like insulin, and that using fake insulin is extremely dangerous and can cause a sharp drop in blood sugar, causing dizziness, seizures and even death.

The incident sheds light on a broader problem in the manufacturing of popular drugs: fake drug lot numbers. Criminal organizations use these batch numbers to distribute potentially deadly counterfeit drugs. Pharmaceutical companies such as Novo Nordisk, the maker of Ozpik, authenticate drug batches by printing specific combinations of letters and numbers on packaging and are used to track products in specific countries. The counterfeit batch number that Drew bought was MP5B060, which was supposed to be the batch number of diabetes drugs destined for Egypt.

The fact that Drew was buying fake drugs in Mexico highlighted the problem, even if, as a consumer, he didn't realize it. Global health authorities are not uniform in regulation, which makes it difficult to ensure the traceability and safety of drugs. Documents reviewed by Reuters and regulatory announcements show that counterfeit drugs with batch number MP5B060 have turned up in at least 10 countries, from Azerbaijan to North Macedonia. Both the World Health Organization (WHO) and Interpol have issued warnings about insulin pens being re-labeled and packaged to mimic Ozempic. Some countries have banned products with this lot number, while others have not.

Mexico's drug regulator didn't respond to requests for comment. The problem has led to hospitalizations in at least four countries. A Reuters investigation found counterfeit Ozempic injections in the United States, Nigeria and Iraq that looked similar to insulin pens. In Iraq, a man fell into a coma after his blood sugar plummeted after taking fake medicine, but eventually recovered.

The incident not only exposed the seriousness of counterfeit drug circulation, but also highlighted the gaps in the global drug regulatory system and the threat these gaps pose to public health.